Pemgarda

Background

Pemgarda, a long-acting antibody, provides prolonged immune protection for immunocompromised individuals and may help suppress SARS-CoV-2 in long COVID cases.

Mechanism of Action

• Pemgarda: Neutralizes SARS-CoV-2 and remains active for about 44 days (FDA Factsheet).

Pros and Cons

• Pros: Extended duration allows continuous immune support; may clear residual viral reservoirs.
• Cons: Requires IV administration and has a 0.6% risk of anaphylaxis.

References

1. FDA Factsheet, Pemgarda
2. Biopharma Media on Pemgarda

‍